Listen

Description

On this week's episode, we explore the world of natriuretic peptides; special signal molecules that help reduce the effects of heart failure. We look at what these peptides are, how they work, and how they are being used in medicine to help those with chronic heart failure.

Acronyms in this article:

Abbreviation | Meaning | Explanation
NP | Natriuretic peptides | A class of signaling molecules found in the blood
Na | Sodium (from natrium) | An key element; part of dietary salt
ANP | Atrial natriuretic peptide | A natriuretic peptide produced in the atria of the heart
BNP | “Brain” natriuretic peptide | A natriuretic peptide produced in the ventricles of the heart
CNP | C-type natriuretic peptide | A natriuretic peptide produced by cells for local communication
NPR1 | Natriuretic peptide receptor-1 | A cellular receptor that senses natriuretic peptides ANP and BNP
NPR-A | Natriuretic peptide receptor-A | Another name for NPR1 (above)
GC-A | Guanylyl cyclase-A | Another name for NPR1 (above), describes the activity inside the cell instead of what activates it
cGMP | Cyclic guanosine monophosphate | Secondary messenger used for signaling inside of cells, activated by guanylyl cyclases

References

Dunn ME, Kithcart A, Kim JH, Ho AJ, Franklin MC, Romero Hernandez A, de Hoon J, Botermans W, Meyer J, Jin X, Zhang D. Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone. Nature. 2024 Sep 19;633(8030):654-61. https://doi.org/10.1038/s41586-024-07903-1

Rao S, Pena C, Shurmur S, Nugent K. Atrial natriuretic peptide: structure, function, and physiological effects: a narrative review. Current Cardiology Reviews. 2021 Nov 1;17(6):17-27. https://doi.org/10.2174/1573403X17666210202102210

Kuhn M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circulation research. 2003 Oct 17;93(8):700-9. https://doi.org/10.1161/01.RES.0000094745.28948.4D

Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine reviews. 2006 Feb 1;27(1):47-72. https://doi.org/10.1210/er.2005-0014

Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovascular research. 2006 Feb 1;69(2):318-28. https://doi.org/10.1016/j.cardiores.2005.10.001

Friebe A, Sandner P, Schmidtko A. cGMP: a unique 2nd messenger molecule–recent developments in cGMP research and development. Naunyn-Schmiedeberg's archives of pharmacology. 2020 Feb;393(2):287-302. https://doi.org/10.1007/s00210-019-01779-z

Marieb EN, Hoehn K. Human anatomy & physiology. [11th Edition]. [Hoboken, New Jersey]: Pearson; [2019]. p.402-403

Curry FR. Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume. The Journal of clinical investigation. 2005 Jun 1;115(6):1458-61. https://doi.org/10.1172/JCI25417

Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro–atrial natriuretic peptide. Circulation: Heart Failure. 2011 Mar;4(2):114-20. https://doi.org/10.1161/CIRCHEARTFAILURE.109.895581

Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube

For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com

Thank you for listening!